AMP Capital Investors’s Heron Therapeutics HRTX Stock Holding History

AMP Capital Investors’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,898	Closed	-$595K	–	1214
2020 Q1	$595K	Hold	50,898	–	–	﹤0.01%	859
2019 Q4	$1.2M	Hold	50,898	–	–	0.01%	834
2019 Q3	$998K	Hold	50,898	–	–	0.01%	876
2019 Q2	$938K	Buy	50,898 +11,906	+31%	+$238K	0.01%	899
2019 Q1	$918K	Hold	38,992	–	–	0.01%	873
2018 Q4	$926K	Sell	38,992 -3,378	-8%	-$92.9K	0.01%	852
2018 Q3	$1.33M	Hold	42,370	–	–	0.01%	831
2018 Q2	$1.65M	Buy	+42,370	New	+$1.35M	0.01%	807

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AMP Capital Investors's HRTX Position: Q2 2020 in Review

AMP Capital Investors sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 50,898 shares — an estimated $595K sold.

AMP Capital Investors first reported a position in HRTX in Q2 2018 and held it in 8 quarters. The position peaked at $1.65M in Q2 2018. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

AMP Capital Investors reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
AMP Capital Investors sold 50,898 Heron Therapeutics shares in Q2 2020, an estimated $595K.
AMP Capital Investors first reported a position in Heron Therapeutics in Q2 2018 and held it in 8 quarters.
AMP Capital Investors's Heron Therapeutics position peaked at $1.65M in Q2 2018.
190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on AMP Capital Investors's 13F filing for Q2 2020, filed 14 Aug 2020.